Mulryne Quoted in The Pink Sheet on Brexit Ramifications for Pharmaceutical Industry
April 5, 2019
Life Sciences and Healthcare Regulatory partner Jacqueline Mulryne was quoted in a recent Pink Sheet article, "Pharma Uncertainty Remains As UK Votes To Delay Brexit." The article considers how UK-based life sciences companies can prepare for the UK's departure from the EU despite uncertainty surrounding the UK's unconfirmed exit deal.
» Read the full article (subscription required).
